Senores Pharmaceuticals Limited is reshaping the finance leadership slate with a recent board decision dated July 27, 2026. The board, on the recommendation of its Nomination and Remuneration Committee, approved the appointment and categorization of Anjali Shah as Assistant Vice President-Finance, designated as Senior Management Personnel (SMP), effective July 27, 2026. The move underscores the company’s intent to fortify its financial leadership as it advances its growth agenda across its global footprint.
Ms. Shah brings over a decade of financial leadership experience to Senores. She is a Chartered Accountant and holds a Bachelor of Commerce degree, with a career spanning finance, taxation, treasury, financial reporting, consolidation, regulatory compliance, internal controls, and cross-border financial management. Notably, she has served as Chief Financial Officer at Remus Pharmaceuticals Ltd., where she led finance functions across domestic and international entities, gaining exposure to IPOs, investor reporting, cash flow management, and stakeholder engagement. Her background positions her to drive enhanced financial discipline and strategic planning as the company scales its operations and product portfolio.
The appointment aligns with Senores’ ongoing expansion and the strengthening of its executive team to support accelerated execution in both regulated and emerging markets. With the AVP-Finance role now in place as SMP, the company is signaling a continued emphasis on robust financial governance, capital allocation, and performance measurement to accompany its growth initiatives, including new manufacturing capabilities and international ventures already highlighted in recent company communications. In parallel, Senores continues to position itself as a global, research-driven player with a diversified portfolio and a strategic push into high-value complex products and injectables.